Related Experiment Video
Updated: Jan 30, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Large Cohort Data Based Cost-Effective Disease Prevention Design Strategy: Strong Heart Study
Wenyu Wang1, Elisa T Lee1, Barbara V Howard2
1Center for American Indian Health Research, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
This study introduces a novel, cost-effective disease prevention strategy using large cohort data to guide clinical practice. The approach addresses challenges in selecting high-risk individuals for intervention and adapting goals for diverse subgroups.
Area of Science:
- Epidemiology
- Public Health
- Biostatistics
Background:
- Large cohort studies generate extensive data on chronic disease incidence and risk factors.
- Current methods for utilizing this data to inform clinical disease prevention are underdeveloped.
- Translating epidemiological findings into practical, cost-effective prevention strategies is a significant challenge.
Purpose of the Study:
- To propose a novel conceptual strategy for cost-effective disease prevention design.
- To address the challenge of intervening in large target groups when universal intervention is unaffordable.
- To provide a framework for translating large cohort study results into clinical practice.
Main Methods:
- Utilized data from the Strong Heart Study, including a diabetes risk prediction model.
- Employed a utility function and regression models to develop the strategy.
- Illustrated the application of the strategy using diabetes prevention as an example.
Main Results:
- A conceptual cost-effective disease prevention design strategy was initiated.
- The strategy was demonstrated through an application to diabetes prevention.
- The approach aims to optimize intervention by identifying high-risk individuals.
Conclusions:
- The proposed strategy offers solutions for cost-effective prevention design, considering complex risk factor associations.
- It facilitates the selection of high-risk individuals, accommodates individual health differences, and sets adaptive intervention goals.
- The strategy and methods are adaptable for preventing other diseases and bridging epidemiological research with clinical application.
Related Concept Videos
Titration Calculations: Strong Acid - Strong Base
A titration is carried out for 25.00 mL of 0.100 M HCl (strong acid) with 0.100 M of a strong base NaOH. The pH at different volumes of added base solution can be calculated as follows:
(a) Titrant volume = 0 mL. The solution pH is due to the acid ionization of HCl. Because this is a strong acid, the ionization is complete and the hydronium ion molarity is 0.100 M. The pH of the solution is then:
Strong Acid and Base Solutions
Titration of a Strong Acid with a Strong Base
Design Example: Setting a Curve Using Design Data
Titration Calculations: Weak Acid - Strong Base
For the titration of 25.00 mL of 0.100 M CH3CO2H with 0.100 M NaOH, the reaction can be represented as:
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

